Qlife Holding AB (OSTO:QLIFE) FCF Margin %: -20,019.05% (As of Mar. 2026)


OSTO:QLIFE Qlife Holding AB OSTO:QLIFE
15 GF Score
Price kr1.93
GF Value kr0.76
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Qlife Holding AB FCF Margin %?

Qlife Holding AB OSTO:QLIFE +1.47% 15 FCF Margin % is -20,019.05% as of Mar. 2026. GuruFocus rates OSTO:QLIFE with a GF Score™ of 15/100 and a GF Value™ of kr0.76 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Qlife Holding AB ranks worse than 97.68% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Qlife Holding AB's Free Cash Flow for the three months ended in Mar. 2026 was kr-4.20 Mil. Qlife Holding AB's Revenue for the three months ended in Mar. 2026 was kr0.02 Mil. Therefore, Qlife Holding AB's FCF Margin % for the quarter that ended in Mar. 2026 was -20,019.05%.

As of today, Qlife Holding AB's current FCF Yield % is -20.86%.

The historical rank and industry rank for Qlife Holding AB's FCF Margin % or its related term are showing as below:

OSTO:QLIFE' s FCF Margin % Range Over the Past 10 Years
Min: -111886   Med: -3567.71   Max: -134.86
Current: -5331.38

During the past 7 years, the highest FCF Margin % of Qlife Holding AB was -134.86%. The lowest was -111886.00%. And the median was -3567.71%.

OSTO:QLIFE's FCF Margin % is ranked worse than
97.68% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: -0.375 vs OSTO:QLIFE: -5331.38

Qlife Holding AB FCF Margin % Related Terms

Qlife Holding AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Qlife Holding AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qlife Holding AB FCF Margin % Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -134.86 -503.93 -25,427.87 -111,886.00 -6,631.48

Qlife Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,621.82 -1,976.92 -7,223.08 -3,646.94 -20,019.05

OSTO:QLIFE vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Qlife Holding AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qlife Holding AB FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's FCF Margin % falls into.


OSTO:QLIFE
15GF Score
Qlife Holding AB OSTO:QLIFE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qlife Holding AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Qlife Holding AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-21.486/0.324
=-6,631.48 %

Qlife Holding AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.204/0.021
=-20,019.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -20,019.05% mean?
Qlife Holding AB (OSTO:QLIFE) has a FCF Margin % of -20,019.05% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Qlife Holding AB and its competitors. According to the industry distribution chart, Qlife Holding AB ranks #799 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 97.7%.
Is Qlife Holding AB's FCF Margin % too high?
Qlife Holding AB's current FCF Margin % is -20,019.05%. Based on the distribution chart, Qlife Holding AB ranks #799 out of 818 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Qlife Holding AB has a GF Score™ of 15/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qlife Holding AB ranks #799 out of 818 companies for FCF Margin %. This places Qlife Holding AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Qlife Holding AB and its competitors. Qlife Holding AB's current FCF Margin % is -20,019.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.76, compared to a current price of kr1.93 — trading 153.9% above its estimated fair value. The current FCF Margin % is -20,019.05%. Qlife Holding AB's overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current FCF Margin % is -20,019.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued. The current stock price of kr1.93 is trading 153.9% above its estimated GF Value™ of kr0.76. GuruFocus considers Qlife Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:QLIFE:

  • FCF Margin %: -20,019.05%
  • GF Value™: kr0.76 vs. price of kr1.93 (153.9% above fair value)
  • GF Score™: 15/100 with 9 warning signs

No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qlife Holding AB Business Description

Other Exchanges 4HG0:Germany
Address Nellikevagen 22, Goteborg, SWE, SE-412 63
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
15GF Score

Get the complete analysis for OSTO:QLIFE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.93
Price
kr0.76
GF Value